Guide · Updated 2026
GLP-1s and Pregnancy
Every GLP-1 is off-limits in pregnancy. If you're planning to conceive, plan the stop date first — the drug lingers for weeks.

Why GLP-1s are contraindicated
Animal studies of semaglutide, tirzepatide, and liraglutide showed increased miscarriage, fetal malformations, and reduced fetal weight at doses similar to human therapeutic doses. Human pregnancy data is limited, but the FDA classifies all GLP-1s as drugs to avoid in pregnancy. The theoretical risk isn't worth taking.
Washout timing
- Semaglutide (Ozempic, Wegovy, Rybelsus): Half-life ~1 week. Fully cleared in ~5 weeks. Stop 8+ weeks before conception.
- Tirzepatide (Mounjaro, Zepbound): Half-life ~5 days. Fully cleared in ~4 weeks. Stop 6–8 weeks before conception.
- Liraglutide (Saxenda, Victoza): Half-life ~13 hours. Fully cleared in ~3 days. Stop 2+ weeks before conception.
Longer washouts are conservative — most clinicians recommend 8 weeks for semaglutide and tirzepatide as a buffer.
Fertility effects
GLP-1s themselves don't improve fertility. But the weight loss they produce can — restoring ovulatory cycles in women with PCOS, improving insulin sensitivity, and reducing pregnancy-related risks like gestational diabetes and preeclampsia. If you're planning a pregnancy and struggling to conceive, losing weight on a GLP-1 first (then stopping) is a legitimate strategy.
Contraception while on treatment
Tirzepatide (Zepbound, Mounjaro) reduces oral contraceptive absorption for 4 weeks after starting and after each dose increase. If you're on tirzepatide and not planning pregnancy, use a non-oral method: IUD, implant, injection, ring, or patch. See our GLP-1 and Birth Control guide.
If you get pregnant unexpectedly
- Stop the injection immediately.
- Call your OB/GYN and your prescribing clinician.
- Enroll in the manufacturer's pregnancy registry (Novo Nordisk and Eli Lilly both maintain them) so future patients benefit from the data.
- Standard prenatal care applies. There's no known intervention needed based on short GLP-1 exposure.
Breastfeeding
No GLP-1 has been studied in human breast milk. Manufacturer labels recommend against use while nursing. If you need to restart for medical reasons (e.g., type 2 diabetes), talk to your OB and pediatrician — the decision is patient-specific.
After delivery
You can restart a GLP-1 after weaning. Many women choose Wegovy or Zepbound to manage postpartum weight retention; discuss timing with your OB, particularly if you had gestational diabetes.
FAQ
Can I take a GLP-1 while pregnant?
No. All GLP-1s (Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, Rybelsus) are contraindicated in pregnancy due to animal studies showing fetal harm.
When should I stop before trying to conceive?
Most guidelines recommend stopping at least 8 weeks before trying — semaglutide has a long half-life and takes 4–5 weeks to fully clear the body.
Do GLP-1s help fertility?
Weight loss on a GLP-1 can restore ovulation in women with PCOS or obesity-related infertility. But you must stop the drug before conception.
What if I accidentally get pregnant?
Stop the drug immediately and call your OB. Available human data doesn't show clear evidence of harm from short exposures, but the risk isn't zero.
Can I take a GLP-1 while breastfeeding?
Not recommended. Semaglutide and tirzepatide haven't been studied in breast milk, and the manufacturer labels advise against it.
See which providers match your situation
Take a 90-second questionnaire and we'll rank your top 3 telehealth providers by medication, budget, and state availability.
Find My Top 3 MatchesEducational content, not medical advice. Talk to a licensed clinician before starting or changing any medication.
